Depressive Symptoms Are Linked To Early Death In Cancer Survivors
5/20/2013
Depressed cancer survivors are twice as likely to die prematurely than those who do not suffer from depression, irrespective of the cancer site. That's according to a new study, by Floortje Mols and colleagues, from Tilburg University in The Netherlands. Their work is published online in Springer's Journal of Cancer Survivorship...
Scheduled Imaging Studies Provide Little Help Detecting Relapse Of Aggressive Lymphoma
5/19/2013
Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found. The overwhelming majority of patients with this aggressive lymphoma already have symptoms, an abnormal physical exam or an abnormal blood test at the time of relapse, the researchers say...
Non-Surgical Treatments For Multiple Tumors Move One Step Closer
5/19/2013
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system. The study is published in Brain: A Journal of Neurology...
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers...
Study Finds Broad Support For Rationing Of Some Types Of Cancer Care
5/18/2013
The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Societ...
Plasmin Delivered Through A Bubble Is More Effective Than TPA In Busting Clots
5/18/2013
A new study from the University of Cincinnati (UC) College of Medicine has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA)...
Advanced Prostate Cancer Drug Xofigo Approved By FDA
5/17/2013
Xofigo (radium Ra 223 dichloride) has been approved by the US FDA for symptomatic late-stage (metastatic) castration-resistant prostate cancer that has reached bones but not other organs, i.e. with no known visceral metastatic disease. The Food and Drug Administration (FDA) approved Xifogo under the priority review program, three months ahead of schedule...
Skin Cancer Link To Lower Risk Of Alzheimer's Disease, Says Study
5/17/2013
People who have skin cancer may be less likely to develop Alzheimer's disease, according to research published this week in Neurology®. Researchers at the Albert Einstein College of Medicine in New York, followed 1,102 people who did not have dementia. They had an average age of 79 and were followed for an average of 3.7 years. 109 people reported that they had skin cancer in the past...
Researchers Discover Master Regulator That Drives Majority Of Lymphoma
5/17/2013
New Findings Show Inhibiting Powerful Protein with New Agents May Supply Broad Benefit for Lymphoma Patients A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein...
Study Suggests Cutaneous Squamous Cell Carcinoma Carries Risk Of Metastasis And Death
5/17/2013
JAMA Dermatology Study Highlights A study by Chrysalyne D. Schmults, M.D., M.S.C.E., of Brigham and Women's Hospital, Boston, and colleagues suggests cutaneous squamous cell carcinoma (CSCC) carries a low but significant risk of metastasis and death. The ten-year retrospective cohort study was conducted at an academic medical center in Boston, and included 985 patients with 1,832 tumors...